599 related articles for article (PubMed ID: 12209729)
41. MIB-1 in endometrial carcinoma: prognostic significance with 5-year follow-up.
Geisler JP; Geisler HE; Miller GA; Wiemann MC; Zhou Z; Crabtree W
Gynecol Oncol; 1999 Dec; 75(3):432-6. PubMed ID: 10600302
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
[TBL] [Abstract][Full Text] [Related]
43. S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome.
Huuhtanen RL; Blomqvist CP; Wiklund TA; Virolainen MJ; Elomaa AI; Pan Y; Tribukait B
Cancer; 1996 May; 77(9):1815-22. PubMed ID: 8646679
[TBL] [Abstract][Full Text] [Related]
44. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
45. Histologic grading of adult soft tissue sarcomas.
Coindre JM
Verh Dtsch Ges Pathol; 1998; 82():59-63. PubMed ID: 10095417
[TBL] [Abstract][Full Text] [Related]
46. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
[TBL] [Abstract][Full Text] [Related]
47. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
Hasegawa T; Yokoyama R; Lee YH; Shimoda T; Beppu Y; Hirohashi S
Oncology; 2000; 58(1):66-74. PubMed ID: 10644943
[TBL] [Abstract][Full Text] [Related]
48. A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern.
Carneiro A; Bendahl PO; Engellau J; Domanski HA; Fletcher CD; Rissler P; Rydholm A; Nilbert M
Cancer; 2011 Mar; 117(6):1279-87. PubMed ID: 21381015
[TBL] [Abstract][Full Text] [Related]
49. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
Golouh R; Bracko M; Novak J
Mod Pathol; 1996 Sep; 9(9):919-24. PubMed ID: 8878024
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
[TBL] [Abstract][Full Text] [Related]
52. Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
Endo M; Tateishi U; Seki K; Yamaguchi U; Nakatani F; Kawai A; Chuman H; Beppu Y
Jpn J Clin Oncol; 2007 Dec; 37(12):955-60. PubMed ID: 18211986
[TBL] [Abstract][Full Text] [Related]
53. Reassessment of the 1993 Osaka grading system for localized soft tissue sarcoma in Japan.
Tomita Y; Morooka T; Hoshida Y; Zhang B; Qiu Y; Nakamichi I; Hamada K; Ueda T; Naka N; Kudawara I; Aozasa K
Anticancer Res; 2006; 26(6C):4665-9. PubMed ID: 17214324
[TBL] [Abstract][Full Text] [Related]
54. Soft tissue sarcoma of the hand.
McPhee M; McGrath BE; Zhang P; Driscoll D; Gibbs J; Peimer C
J Hand Surg Am; 1999 Sep; 24(5):1001-7. PubMed ID: 10509279
[TBL] [Abstract][Full Text] [Related]
55. Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence.
Engellau J
Acta Orthop Scand Suppl; 2004 Dec; 75(314):2 p preceding table of contents-52, backcover. PubMed ID: 15678700
[TBL] [Abstract][Full Text] [Related]
56. Prognosis for soft-tissue sarcoma in the locomotor system. A retrospective population-based follow-up study of 237 patients.
Rydholm A; Berg NO; Gullberg B; Persson BM; Thorngren KG
Acta Pathol Microbiol Immunol Scand A; 1984 Sep; 92(5):375-86. PubMed ID: 6507102
[TBL] [Abstract][Full Text] [Related]
57. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
[TBL] [Abstract][Full Text] [Related]
58. Serum albumin is an independent prognostic factor for survival in soft tissue sarcomas.
Barreto-Andrade JC; Medina-Franco H
Rev Invest Clin; 2009; 61(3):198-204. PubMed ID: 19736808
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.
ten Heuvel SE; Hoekstra HJ; van Ginkel RJ; Bastiaannet E; Suurmeijer AJ
Ann Surg Oncol; 2007 Jan; 14(1):222-9. PubMed ID: 17058128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
